GNMX.US Corgi Genomics & Precision Medicine ETF
- Total assets
- -
- Expense ratio
- -
- Dividend yield
- -
- 1-year return
- -
- Holdings
- 10
- Since
- -
Fund data as reported by the issuer, updated Nov 12, 2026. Total assets are in the fund's base currency.
What does GNMX.US invest in?
- Top 3 holdings: 25.0% of the fund
Top holdings
- Moderna Inc 10.12%
- Thermo Fisher Scientific Inc 8.79%
- Vertex Pharmaceuticals Inc 6.09%
- Genmab AS 4.66%
- Illumina Inc 4.07%
Corgi Genomics & Precision Medicine ETF performance
Return figures of Corgi Genomics & Precision Medicine ETF are not available yet.
GNMX.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Corgi Genomics & Precision Medicine ETF
The fund is an ETF that seeks to meet its objective by having Corgi Strategies, LLC actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the research, development, and commercialization of genomics and precision medicine technologies that enable improved disease detection, identifying and grouping patients based on genetic, molecul…
Full fund profileCorgi Genomics & Precision Medicine ETF top holdings
48.7% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 10.12% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 8.79% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 6.09% |
| Genmab AS GMAB.US | Healthcare | United States | 4.66% |
| Illumina Inc ILMN.US | Healthcare | United States | 4.07% |
| Guardant Health Inc GH.US | Healthcare | United States | 3.79% |
| Revolution Medicines Inc RVMD.US | Healthcare | United States | 3.12% |
| 10X Genomics Inc TXG.US | Healthcare | United States | 2.91% |
| Incyte Corporation INCY.US | Healthcare | United States | 2.76% |
| First American Funds Inc. - Government Obligations Fund FGXXX.US | - | United States | 2.38% |
Corgi Genomics & Precision Medicine ETF fund profile
- Fund name
- Corgi Genomics & Precision Medicine ETF
- Ticker
- GNMX.US
- Exchange
- USA Stocks
- Issuer
- -
- Index tracked
- -
- Category
- -
- Inception date
- -
- Trading currency
- USD
- Expense ratio
- -
About Corgi Genomics & Precision Medicine ETF
The fund is an ETF that seeks to meet its objective by having Corgi Strategies, LLC actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the research, development, and commercialization of genomics and precision medicine technologies that enable improved disease detection, identifying and grouping patients based on genetic, molecular, or clinical characteristics to guide treatment decisions, targeted therapies, and data-driven healthcare. It is non-diversified.